
Cadila Healthcare Limited has informed the Exchange regarding a press release dated May 28, 2021, titled "Zydus new tech enabled initiative to safeguard patients against counterfeit drugs".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated May 28, 2021, titled "Zydus new tech enabled initiative to safeguard patients against counterfeit drugs".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences